These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 364284)

  • 1. Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: a prognostic factor comparison of two regimens.
    Cabanillas F; Rodriguez V; Freireich EJ
    Med Pediatr Oncol; 1978; 4(4):321-31. PubMed ID: 364284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study.
    Jones SE; Grozea PN; Metz EN; Haut A; Stephens RL; Morrison FS; Butler JJ; Byrne GE; Moon TE; Fisher R; Haskins CL; Coltman CA
    Cancer; 1979 Feb; 43(2):417-25. PubMed ID: 84706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
    McKelvey EM; Gottlieb JA; Wilson HE; Haut A; Talley RW; Stephens R; Lane M; Gamble JF; Jones SE; Grozea PN; Gutterman J; Coltman C; Moon TE
    Cancer; 1976 Oct; 38(4):1484-93. PubMed ID: 791473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined modality therapy of diffuse histology non-Hodgkin's lymphoma with cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and total body irradiation.
    Weick JK; Antunez A; Kraus TA; Fabian CJ; Dixon D
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1205-7. PubMed ID: 6347997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP).
    Elias L; Portlock CS; Rosenberg SA
    Cancer; 1978 Oct; 42(4):1705-10. PubMed ID: 361209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.
    Cabanillas F; Burgess MA; Bodey GP; Freireich EJ
    Am J Med; 1983 Mar; 74(3):382-8. PubMed ID: 6187213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of chemotherapy CHOP vs. CHOP/VIA in the treatment of aggressive non-Hodgkin's lymphoma: a randomized multicenter study of 132 patients. The PETHEMA group. Program for Study and Therapeutics of malignant hemopathies. Spanish Association of Hematology and Hemotherapy].
    López-Guillermo A; García-Conde J; Alvarez-Carmona AM; León P; Maldonado J; Alcalá A; Zubizarreta A; Sancho-Tello R; Carbonell F; Contreras E; Besses C; Hernando A; Fontanillas M; Montserrat E
    Med Clin (Barc); 1998 May; 110(16):601-4. PubMed ID: 9656196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.
    Mori M; Kitamura K; Masuda M; Hotta T; Miyazaki T; Miura AB; Mizoguchi H; Shibata A; Saito H; Matsuda T; Masaoka T; Harada M; Niho Y; Takaku F
    Int J Hematol; 2005 Apr; 81(3):246-54. PubMed ID: 15814336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of cyclophosphamide, vincristine, and prednisone, followed by maintenance chemotherapy, with and without radiotherapy, in the management of patients with non-Hodgkin's lymphomas.
    Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
    Med Pediatr Oncol; 1977; 3(1):41-51. PubMed ID: 320448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential cyclophosphamide-prednisone and vincristine-bleomycin (CPOB). An effective, schedule-dependent treatment for advanced diffuse histiocytic lymphoma.
    Johnson GJ; Costello WG; Oken MM; Sponzo RW; Barnes JM; Ezdinli EZ; Bennett JM; Silverstein MN; Glick JH; Berard CW
    Cancer; 1983 Oct; 52(7):1133-41. PubMed ID: 6192894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy. A Southwest Oncology Group Study.
    Jones SE; Grozea PN; Metz EN; Haut A; Stephens RL; Morrison FS; Talley R; Butler JJ; Byrne GE; Hartsock R; Dixon D; Salmon SE
    Cancer; 1983 Mar; 51(6):1083-90. PubMed ID: 6185212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of diffuse histiocytic and diffuse mixed non-Hodgkin lymphomas with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP).
    Cohen Y; Epelbaum R; Ben-Shahar M; Ron Y; Haim N
    Acta Oncol; 1988; 27(5):531-5. PubMed ID: 3203011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP).
    Armitage JO; Dick FR; Corder MP; Garneau SC; Platz CE; Slymen DJ
    Cancer; 1982 Nov; 50(9):1695-702. PubMed ID: 6749279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).
    Skarin AT; Rosenthal DS; Moloney WC; Frei E
    Blood; 1977 May; 49(5):759-70. PubMed ID: 66957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in chemotherapy for large cell lymphoma.
    Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin's lymphoma.
    Fisher RI
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S42-6. PubMed ID: 9272133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
    Sampi K; Honda T; Hattori M; Takayama S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study.
    Grozea PN; Jones SE; McKelvey EM; Coltman CA; Fisher R; Haskins CL
    Cancer Treat Rep; 1979 Apr; 63(4):647-53. PubMed ID: 87277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma.
    Rodriguez V; Cabanillas F; Burgess MA; McKelvey EM; Valdivieso M; Bodey GP; Freireich EJ
    Blood; 1977 Mar; 49(3):325-33. PubMed ID: 65189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.